skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

56 studies were found about ( fosamprenavir OR Lexiva )

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

Condition: Infection, Human Immunodeficiency Virus I; HIV-1 Infection

NCT ID: NCT00450580

A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects

Condition: HIV Infection; Infection, Human Immunodeficiency Virus

NCT ID: NCT00363142

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Condition: Chronic HIV Infection; HCV Coinfection

NCT ID: NCT01222611

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00242840

Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects

Condition: Hypertriglyceridemia; HIV Infection

NCT ID: NCT01010399

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

Condition: Opioid Dependency; HIV Infections

NCT ID: NCT00877591

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

Condition: HIV Infections

NCT ID: NCT00025727

Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT00008554

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Condition: HIV Infections

NCT ID: NCT00028366

Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)

Condition: HIV Infections

NCT ID: NCT00122603

Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00071760

Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00207948

Fosamprenavir Versus Other Protease Inhibitors

Condition: Human Immunodeficiency Virus I Infection; HIV Infection

NCT ID: NCT00094523

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

Condition: HIV Infections

NCT ID: NCT00307502

A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years

Condition: HIV Infection

NCT ID: NCT00040664

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Condition: HIV Infection; Infection, Human Immunodeficiency Virus

NCT ID: NCT00085943

Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects

Condition: HIV-1

NCT ID: NCT00144833

A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00296504

Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut

Condition: HIV Infections

NCT ID: NCT00884793

Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study

Condition: HIV Infections

NCT ID: NCT00537966

Fosamprenavir Expanded Access

Condition: HIV Infection

NCT ID: NCT00240552

Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

Condition: HIV Infections

NCT ID: NCT00009061

"The Once A Day Protease Inhibitor Regimens"

Condition: HIV Infections

NCT ID: NCT00242216

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Condition: HIV Infections

NCT ID: NCT00043888

A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir

Condition: HIV Infections

NCT ID: NCT00148785

Clinical Trial of CNS-targeted HAART (CIT2)

Condition: HIV Infections

NCT ID: NCT00624195

48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT00089583

HIV Treatment and CVD Events

Condition: HIV Infection; Cardiovascular Disease; Infection, Human Immunodeficiency Virus; Acute Myocardial Infarction

NCT ID: NCT01054638

PENTA Fosamprenavir Study

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01077635

Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)

Condition: HIV Infections

NCT ID: NCT00977301

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r

Condition: HIV Infections

NCT ID: NCT00756730

MARCH Central Nervous System Substudy

Condition: HIV-1 Infection

NCT ID: NCT01637233

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Condition: HIV Infections

NCT ID: NCT00027339

Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir

Condition: HIV Infection; Fungal Infection

NCT ID: NCT00817765

Fosamprenavir in Pts With Hepatic Impairment

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01054586

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01137981

A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination

Condition: HIV

NCT ID: NCT00335270

Maraviroc Switch Collaborative Study

Condition: HIV

NCT ID: NCT01384682

A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT

Condition: Human Immunodeficiency Virus Infections

NCT ID: NCT00727597

MARCH Renal Substudy

Condition: Proteinuria; HIV

NCT ID: NCT01637259

GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae

NCT ID: NCT01209065

VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.

Condition: Hepatitis C; Telaprevir; HIV

NCT ID: NCT00775125

Comparative Tolerability of Protease Inhibitors

Condition: HIV

NCT ID: NCT01450618

Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status

Condition: Fracture; Infection, Human Immunodeficiency Virus

NCT ID: NCT01077557

Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients

Condition: HIV-1 Infection; AIDS

NCT ID: NCT01348308

Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents

Condition: ADHD; HIV

NCT ID: NCT01232361

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

Condition: HIV; HIV Infections

NCT ID: NCT00966329

Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product

Condition: HIV Infections

NCT ID: NCT00773708

IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients

Condition: HIV Infections

NCT ID: NCT00935480

Two Part Study to Study Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir (EVG) Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Subjects

Condition: Acquired Immune Deficiency Syndrome (AIDS); HIV Infections

NCT ID: NCT01923311

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Condition: Human Immunodeficiency Virus; Hepatitis B, Chronic; Hepatitis C, Chronic

NCT ID: NCT01908660

Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

Condition: HIV Infection

NCT ID: NCT00707733

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Condition: HIV-1 Infection

NCT ID: NCT01252940

Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.

Condition: Healthy Subjects

NCT ID: NCT00481182

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Condition: Healthy

NCT ID: NCT01290211

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Condition: Healthy

NCT ID: NCT01140412